Frontiers in Cardiovascular Medicine (Jul 2022)
Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
Abstract
No abstracts available.Keywords
Frontiers in Cardiovascular Medicine (Jul 2022)